nocodazole has been researched along with Malignant Melanoma in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nuclear iASPP is enriched in melanoma metastasis and associates with poor patient survival." | 1.39 | Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP. ( Baer, C; Breyssens, H; Brown, NR; Caballero, OL; Cebon, J; Endicott, J; Goding, CR; Hu, Y; John, T; Jones, EY; Kessler, BM; Knapp, S; Lu, M; Lu, X; Middleton, MR; Ratnayaka, I; Salter, V; Siebold, C; Sullivan, A; Sviderskaya, EV; Zhong, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Mahboobi, S | 1 |
| Pongratz, H | 1 |
| Hufsky, H | 1 |
| Hockemeyer, J | 1 |
| Frieser, M | 1 |
| Lyssenko, A | 1 |
| Paper, DH | 1 |
| Bürgermeister, J | 1 |
| Böhmer, FD | 1 |
| Fiebig, HH | 1 |
| Burger, AM | 1 |
| Baasner, S | 1 |
| Beckers, T | 1 |
| Endo, Y | 1 |
| Saeki, K | 1 |
| Watanabe, M | 1 |
| Miyajima-Magara, N | 1 |
| Igarashi, M | 1 |
| Mochizuki, M | 1 |
| Nishimura, R | 1 |
| Sugano, S | 1 |
| Sasaki, N | 1 |
| Nakagawa, T | 1 |
| Lu, M | 1 |
| Breyssens, H | 1 |
| Salter, V | 1 |
| Zhong, S | 1 |
| Hu, Y | 1 |
| Baer, C | 1 |
| Ratnayaka, I | 1 |
| Sullivan, A | 1 |
| Brown, NR | 1 |
| Endicott, J | 1 |
| Knapp, S | 1 |
| Kessler, BM | 1 |
| Middleton, MR | 1 |
| Siebold, C | 1 |
| Jones, EY | 1 |
| Sviderskaya, EV | 1 |
| Cebon, J | 1 |
| John, T | 1 |
| Caballero, OL | 1 |
| Goding, CR | 1 |
| Lu, X | 1 |
| Spangler, B | 1 |
| Kappelmann, M | 1 |
| Schittek, B | 1 |
| Meierjohann, S | 1 |
| Vardimon, L | 1 |
| Bosserhoff, AK | 1 |
| Kuphal, S | 1 |
| Wang, Q | 1 |
| Moyret-Lalle, C | 1 |
| Couzon, F | 1 |
| Surbiguet-Clippe, C | 1 |
| Saurin, JC | 1 |
| Lorca, T | 1 |
| Navarro, C | 1 |
| Puisieux, A | 1 |
| Sjoberg, ER | 1 |
| Chammas, R | 1 |
| Ozawa, H | 1 |
| Kawashima, I | 1 |
| Khoo, KH | 1 |
| Morris, HR | 1 |
| Dell, A | 1 |
| Tai, T | 1 |
| Varki, A | 1 |
| Fink-Puches, R | 1 |
| Hofmann-Wellenhof, R | 1 |
| Smolle, J | 1 |
| Helige, C | 1 |
| Kerl, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Decitabine and Arsenic Trioxide(ATO) in the Treatment of Myelodysplasic Syndrome[NCT03377725] | Phase 3 | 0 participants (Actual) | Interventional | 2018-03-20 | Withdrawn (stopped due to No patient was involved.) | ||
| Decitabine,Cytarabine(Ara-C) and Arsenic Trioxide(ATO) in the Treatment of Acute Myeloid Leukemia With p53 Mutations[NCT03381781] | Phase 2 | 100 participants (Anticipated) | Interventional | 2018-03-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 other studies available for nocodazole and Malignant Melanoma
| Article | Year |
|---|---|
Synthetic 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents.
Topics: Allantois; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Biopolymers; Cattle; Chorion; Dr | 2001 |
Spindle assembly checkpoint competence in aneuploid canine malignant melanoma cell lines.
Topics: Aneuploidy; Animals; Cell Cycle Proteins; Cell Line, Tumor; Chromatids; Dog Diseases; Dogs; Histones | 2020 |
Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; CDC2 Protein Kinase; Cell | 2013 |
Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; CDC2 Protein Kinase; Cell | 2013 |
Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; CDC2 Protein Kinase; Cell | 2013 |
Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; CDC2 Protein Kinase; Cell | 2013 |
ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma.
Topics: Cadherins; Cell Line, Tumor; Cytoskeleton; Humans; Melanoma; Nocodazole; Promoter Regions, Genetic; | 2012 |
Alterations of anaphase-promoting complex genes in human colon cancer cells.
Topics: Anaphase-Promoting Complex-Cyclosome; Antineoplastic Agents; Apc3 Subunit, Anaphase-Promoting Comple | 2003 |
Expression of de-N-acetyl-gangliosides in human melanoma cells is induced by genistein or nocodazole.
Topics: Antibodies, Monoclonal; Benzoquinones; Cell Line; Chromatography, High Pressure Liquid; Chromatograp | 1995 |
Cytoplasmic microtubules in two different mouse melanoma cell lines: a qualitative and quantitative analysis using confocal laser scanning microscopy and computer-assisted image analysis.
Topics: Animals; Female; Fluorescent Antibody Technique, Indirect; Image Processing, Computer-Assisted; Mela | 1997 |